Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine
Main Authors: | , , , , , , , , , , , , , , |
---|---|
格式: | Conference item |
出版: |
BMJ Publishing Group
2018
|